Summary
A recent discussion focuses on the effectiveness of oral versus intramuscular vitamin B12 supplementation for patients with vitamin B12 deficiency. Karen Chan, a family doctor and associate professor, highlights the ongoing debate about whether monthly injections or daily oral pills are more beneficial. Historically, intramuscular injections have been the standard treatment, but recent evidence suggests that oral supplementation may be equally effective.
Chan and her colleagues reviewed several randomized controlled trials (RCTs) involving a total of 153 patients with varying causes of vitamin B12 deficiency. Their findings indicate that both oral and intramuscular administration led to similar improvements in vitamin B12 levels and associated symptoms, including anemia and neurological issues. Despite some limitations in the studies, such as small sample sizes and open-label designs, the overall results support the use of oral vitamin B12 as a viable alternative.
The discussion also addresses the prevalence of vitamin B12 deficiency, particularly among the elderly, and identifies risk factors such as dietary restrictions and certain medications. Chan emphasizes the importance of addressing this deficiency, especially in vulnerable populations, and suggests that transitioning to oral supplementation could result in significant cost savings for healthcare systems. The consensus is that oral vitamin B12 is just as effective as injections for most patients, challenging the long-held belief that injections are superior.
Show Notes
In episode 630, Jamie and James invite Karenn Chan back to the podcast and we go over all the evidence to answer the question, is giving oral vitamin B12 as effective as intramuscular vitamin B12? Lots of people still get these intramuscular shots, but have a listen to the podcast to see if this really still makes sense. Show Notes Tools For Practice Vitamin B12 Deficiency: Monthly shots or daily pills? To claim your CPD credits, click the link below and then select "Claim Credits Now". https://cfpclearn.ca/podcast/bs630/
More from CFPCLearn
In episode 629, Jamie and James invite Karenn Chan to the podcast for the first time. We go over the evidence for the very important topic of if and when to stop medications for dementia. We'll give you all the numbers you need to have informed conversations with patients and caregivers of people with dementia. Have a listen and hopefully you will find the discussion useful. Show Notes Tools For Practice Deprescribing Cholinesterase Inhibitors: Good or bad idea? To claim your CPD credits, click the link below and then select "Claim Credits Now". https://cfpclearn.ca/podcast/bs629/
In episode 628, Jamie and James invite Jennifer Young back to the podcast to talk about the very important topic of sleep and what to use instead of medications. We go over all the evidence for cognitive behavioural therapy for insomnia and the numbers look pretty impressive. Have a listen and hopefully you will be impressed by the benefit. Show Notes 1) Tools For Practice Enough Evidence to Put One to Sleep: Cognitive behavioural therapy for insomnia 2) Great Insomnia Website Sleepwell To claim your CPD credits, click the link below and then select "Claim Credits Now". https://cfpclearn.ca/podcast/bs628/
In episode 627, Tina and James again invite Danielle Perry and Caitlin Finley back to the podcast to answer the question, in children with peanut allergy, does oral immunotherapy increase peanut tolerance, and what are the adverse effects? It does work, but it is not a cure, so you need to know the numbers and the important context – you'll get this from this podcast. Show Notes Tools For Practice A Tough Nut to Crack: Does oral immunotherapy improve outcomes in peanut allergy? To claim your CPD credits, click the link below and then select "Claim Credits Now". https://cfpclearn.ca/podcast/bs627/
In this module of In the Clinic, the team discusses Diana Neer, a 64-year-old woman complaining of shoulder pain. To claim your CPD credits, click the link below and then select "Complete Activity." https://cfpclearn.ca/podcast/itc62/
In episode 626, Tina and James invite Caitlin Finley and Danielle Perry to the podcast to discuss the evidence for using hydrocortisone or pimecrolimus for atopic dermatitis in patients under the age of 2. They do work, so check out the podcast for all the numbers and the important context. Show Notes Tools For Practice Itchy Beginnings: Can we calm infant eczema? To claim your CPD credits, click the link below and then select "Claim Credits Now". https://cfpclearn.ca/podcast/626/